| pubmed-article:10714221 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10714221 | lifeskim:mentions | umls-concept:C0014260 | lld:lifeskim |
| pubmed-article:10714221 | lifeskim:mentions | umls-concept:C0018923 | lld:lifeskim |
| pubmed-article:10714221 | lifeskim:mentions | umls-concept:C1171362 | lld:lifeskim |
| pubmed-article:10714221 | lifeskim:mentions | umls-concept:C0005516 | lld:lifeskim |
| pubmed-article:10714221 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
| pubmed-article:10714221 | lifeskim:mentions | umls-concept:C1515670 | lld:lifeskim |
| pubmed-article:10714221 | lifeskim:mentions | umls-concept:C0205369 | lld:lifeskim |
| pubmed-article:10714221 | pubmed:dateCreated | 2000-4-4 | lld:pubmed |
| pubmed-article:10714221 | pubmed:abstractText | Angiosarcomas apparently derive from endothelia of the blood vasculature, however occasionally their histologic features suggest mixed origin from blood and lymphatic endothelia. In the absence of specific positive markers for lymphatic endothelia the precise distinction between these components was not possible so far. Here we provide evidence that podoplanin, a approximately 38 kD membrane glycoprotein of podocytes is a specific marker of lymphatic endothelium that was used to identify the relative fraction of tumor cells with lymphatic or blood vascular endothelial phenotype in vascular tumors. | lld:pubmed |
| pubmed-article:10714221 | pubmed:language | ger | lld:pubmed |
| pubmed-article:10714221 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10714221 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10714221 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10714221 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10714221 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10714221 | pubmed:issn | 0070-4113 | lld:pubmed |
| pubmed-article:10714221 | pubmed:author | pubmed-author:AmannGG | lld:pubmed |
| pubmed-article:10714221 | pubmed:author | pubmed-author:KerjaschkiDD | lld:pubmed |
| pubmed-article:10714221 | pubmed:author | pubmed-author:KowalskiHH | lld:pubmed |
| pubmed-article:10714221 | pubmed:author | pubmed-author:HorvatRR | lld:pubmed |
| pubmed-article:10714221 | pubmed:author | pubmed-author:Breiteneder-G... | lld:pubmed |
| pubmed-article:10714221 | pubmed:author | pubmed-author:SoleimanAA | lld:pubmed |
| pubmed-article:10714221 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10714221 | pubmed:volume | 83 | lld:pubmed |
| pubmed-article:10714221 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10714221 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10714221 | pubmed:pagination | 270-5 | lld:pubmed |
| pubmed-article:10714221 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:10714221 | pubmed:meshHeading | pubmed-meshheading:10714221... | lld:pubmed |
| pubmed-article:10714221 | pubmed:meshHeading | pubmed-meshheading:10714221... | lld:pubmed |
| pubmed-article:10714221 | pubmed:meshHeading | pubmed-meshheading:10714221... | lld:pubmed |
| pubmed-article:10714221 | pubmed:meshHeading | pubmed-meshheading:10714221... | lld:pubmed |
| pubmed-article:10714221 | pubmed:meshHeading | pubmed-meshheading:10714221... | lld:pubmed |
| pubmed-article:10714221 | pubmed:meshHeading | pubmed-meshheading:10714221... | lld:pubmed |
| pubmed-article:10714221 | pubmed:meshHeading | pubmed-meshheading:10714221... | lld:pubmed |
| pubmed-article:10714221 | pubmed:meshHeading | pubmed-meshheading:10714221... | lld:pubmed |
| pubmed-article:10714221 | pubmed:meshHeading | pubmed-meshheading:10714221... | lld:pubmed |
| pubmed-article:10714221 | pubmed:meshHeading | pubmed-meshheading:10714221... | lld:pubmed |
| pubmed-article:10714221 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:10714221 | pubmed:articleTitle | [Podoplanin--a specific marker for lymphatic endothelium expressed in angiosarcoma]. | lld:pubmed |
| pubmed-article:10714221 | pubmed:affiliation | Klinisches Institut für Klinische Pathologie, AKH Wien, Universität Wien, Austria. | lld:pubmed |
| pubmed-article:10714221 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10714221 | pubmed:publicationType | English Abstract | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10714221 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10714221 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10714221 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10714221 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10714221 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10714221 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10714221 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10714221 | lld:pubmed |
